AMELIA WILLIAMSON: Open Payments
NPI 1932729399 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 17 payments from 10 companies in 2025. Trend: 2023 $457 · 2024 $212 · 2025 $685
Food & beverage: $685
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 2 | $149 |
| NxStage Medical, Inc. | 2 | $134 |
| Calliditas Therapeutics US Inc. | 1 | $122 |
| United Therapeutics Corporation | 3 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Actelion Pharmaceuticals US, Inc. | 1 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $17 |
| Baxter Healthcare | 1 | $15 |
Products named: NXSTAGE SYSTEM ONE, XPHOZAH 30 MG, TARPEYO, Tyvaso, ZERBAXA, OPSUMIT, OFEV, Orenitram.
Industry payments across AL — which companies pay providers there.
